Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Curiel

Showing results (141-150 of 400) with videos related to

Pageof 40
Sort By:
Viruses|October 27, 2022
A Novel Piggyback Strategy for mRNA Delivery Exploiting Adenovirus Entry BiologyMyungeun Lee, Paul J Rice-Boucher, Logan Thrasher Collins, et al.
Virus Research|November 19, 2005
Generation and selection of targeted adenoviruses embodying optimized vector propertiesSam C Noureddini, Alexander Krendelshchikov, Vera Simonenko, et al.
Journal of Virology|November 5, 2002
Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or productionHuang-Ge Zhang, Jinfu Xie, Igor Dmitriev, et al.
Vaccine|May 10, 2017
A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in miceJairo A Fonseca, Jessica N McCaffery, Elena Kashentseva, et al.
Cancer Biology & Therapy|August 19, 2008
Searching for a cure: gene therapy for glioblastomaPaul Dent, Adly Yacoub, Margaret Park, et al.
Molecular Cancer Therapeutics|November 21, 2007
Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cellsLuni Emdad, Irina V Lebedeva, Zao-Zhong Su, et al.
International Journal of Cancer|September 4, 2007
Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenovirusesStephan Schierer, Andrea Hesse, Ina Müller, et al.
The Journal of Gene Medicine|January 31, 2016
Pulmonary vasculature directed adenovirus increases epithelial lining fluid alpha-1 antitrypsin levelsMaurizio Buggio, Christopher Towe, Anand Annan, et al.
Molecular Cancer Therapeutics|August 26, 2010
Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacyJoshua J Short, Angel A Rivera, Hongju Wu, et al.
Cancer Research|March 13, 2002
The flt-1 promoter for transcriptional targeting of teratocarcinomaGerd J Bauerschmitz, Dirk M Nettelbeck, Anna Kanerva, et al.
Pageof 40

Showing results (141-150 of 400) with videos related to

Sort By:
Pageof 40
Viruses|October 27, 2022
A Novel Piggyback Strategy for mRNA Delivery Exploiting Adenovirus Entry BiologyMyungeun Lee, Paul J Rice-Boucher, Logan Thrasher Collins, et al.
Virus Research|November 19, 2005
Generation and selection of targeted adenoviruses embodying optimized vector propertiesSam C Noureddini, Alexander Krendelshchikov, Vera Simonenko, et al.
Journal of Virology|November 5, 2002
Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or productionHuang-Ge Zhang, Jinfu Xie, Igor Dmitriev, et al.
Vaccine|May 10, 2017
A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in miceJairo A Fonseca, Jessica N McCaffery, Elena Kashentseva, et al.
Cancer Biology & Therapy|August 19, 2008
Searching for a cure: gene therapy for glioblastomaPaul Dent, Adly Yacoub, Margaret Park, et al.
Molecular Cancer Therapeutics|November 21, 2007
Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cellsLuni Emdad, Irina V Lebedeva, Zao-Zhong Su, et al.
International Journal of Cancer|September 4, 2007
Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenovirusesStephan Schierer, Andrea Hesse, Ina Müller, et al.
The Journal of Gene Medicine|January 31, 2016
Pulmonary vasculature directed adenovirus increases epithelial lining fluid alpha-1 antitrypsin levelsMaurizio Buggio, Christopher Towe, Anand Annan, et al.
Molecular Cancer Therapeutics|August 26, 2010
Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacyJoshua J Short, Angel A Rivera, Hongju Wu, et al.
Cancer Research|March 13, 2002
The flt-1 promoter for transcriptional targeting of teratocarcinomaGerd J Bauerschmitz, Dirk M Nettelbeck, Anna Kanerva, et al.
Pageof 40